U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673263) titled 'Effects of X Box Kinect 360 in Alzheimer's Disease' on June 23.
Brief Summary: Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).
Study Start Date: June 24
Study Type: INTERVENTIONAL
Condition:
Alzheimer s Disease
Intervention:
OTHER: 3D Kinect based game
Experimental group will receive X boc kinect 360 bomb s...